|Articles|February 1, 2000

February 2000
Volume 6
Issue 2

Ischemic Stroke: Acute Management and Secondary Prevention

Author(s)John Sparks, MD, Thomas Rea, MD

Download PDF: Ischemic Stroke: Acute Management and Secondary Prevention

Articles in this issue

almost 26 years ago

Article

Barriers to Using Cost-Effectiveness Analysis in Managed Cae Decision Making

almost 26 years ago

Article

Asking Women to See Nurses or Unfamiliar Physicians as Part of Primary Care Redesign

almost 26 years ago

Article

Cost of Treating Influenza in Emergency Department and Hospital Settings

almost 26 years ago

Article

Hospital Resource Consumption in Patients with Diabetes and Multivessel Coronary Disease Undergoing Revascularization

almost 26 years ago

Article

Is Cost-Effectiveness Modeling Useful?

almost 26 years ago

Article

Cost-Effectiveness Analysis under Managed Care: Not Yet Ready for Prime Time?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

A Health Economic Evaluation of Digital Digestive Care Management

ByMartha Shepherd, DO, MPH,Pen-Che Ho, MS,David Hines, BA,Jon Harris-Shapiro, BA,Dena Bravata, MD, MS,Christopher M. Whaley, PhD,K. Davina Frick, PhD,Emmanuel F. Drabo, PhD,Ron Z. Goetzel, PhD

January 21st 2026

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

ByShamsi Atefeh, PhD

January 15th 2026

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

ByMohamed M. Ali, MS,Scott Lunos, MS,Zachary Henderson, BSB,Michele Allen, MD, MS,Patricia Adam, MD, MSPH,Genevieve B. Melton, MD, PhD,Rubina Rizvi, MD, PhD

January 12th 2026

Subjective and Objective Impacts of Ambulatory AI Scribes

ByJulia Adler-Milstein, PhD,Orianna DeMasi, PhD,Hossein Soleimani, PhD,Sarah Beck, MDiv,Maria E. Byron, MD,Aris Oates, MD,Robert Thombley, BS,Jinoos Yazdany, MD, MPH,Sara G. Murray, MD, MAS

January 8th 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Ischemic Stroke: Acute Management and Secondary Prevention

Articles in this issue

Newsletter

Related Content

Specialty and Operator Status Influence Electronic Health Record Use Variation

A Health Economic Evaluation of Digital Digestive Care Management

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

Subjective and Objective Impacts of Ambulatory AI Scribes

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

Congress Unveils Massive Funding Bill to Avert Shutdown

ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC

Novel CLL Therapies Prompt New Treatment Considerations

Early Data Show Feasibility of in Vivo CAR T Therapy in Multiple Myeloma

Health Insurance CEOs Questioned by House Committee About Rising Costs in Health Care